JO
OCEA

John Overdeck’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

John Overdeck’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,871
Closed -$1.07K – 3666
2025
Q1 		$1.07K Buy
+19,871
New +$4.75K ﹤0.01% 3160
2024
Q1 		– Sell
-25,512
Closed -$16.8K – 3442
2023
Q4 		$16.8K Buy
+25,512
New +$35K ﹤0.01% 3057

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Vanguard Personalized Indexing Management
Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

John Overdeck's OCEA Position: Q2 2025 in Review

John Overdeck sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 19,871 shares — an estimated $1.07K sold.

John Overdeck first reported a position in OCEA in Q4 2023 and held it in 2 quarters. The position peaked at $16.8K in Q4 2023. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • John Overdeck reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • John Overdeck sold 19,871 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $1.07K.
  • John Overdeck first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • John Overdeck's Ocean Biomedical, Inc. Common Stock position peaked at $16.8K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.